{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:10:31Z","timestamp":1784549431200,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002992","name":"Department for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002992","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","award":["MR\/S005293\/1"],"award-info":[{"award-number":["MR\/S005293\/1"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022287","name":"International Molybdenum Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018336","name":"National Institute for Health Research Health Protection Research Unit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV-039626"],"award-info":[{"award-number":["INV-039626"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["214320"],"award-info":[{"award-number":["214320"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijid.2026.108396","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:11:44Z","timestamp":1768435904000},"page":"108396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Seroprevalence of antibodies against diphtheria, tetanus, and pertussis over a 12-year period in children in Kilifi, Kenya (2009-2021)"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6362-3537","authenticated-orcid":false,"given":"Caroline N.","family":"Mburu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ojal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Ombati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Akech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boniface","family":"Karia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Tuju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antipa","family":"Sigilai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaby","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.M.","family":"van Gageldonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona R.M.","family":"van der Klis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Flasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice W.","family":"Kagucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jag","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imo","family":"Adetifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108396_bib0001","author":"Cines"},{"key":"10.1016\/j.ijid.2026.108396_bib0002","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2458-6-132","article-title":"Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis B virus antigens","volume":"6","author":"Ndiritu","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijid.2026.108396_bib0003","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.vaccine.2017.02.034","article-title":"Electronic address: sageexecsec@who.int. Tetanus vaccines: WHO position paper, February 2017 \u2013 recommendations","volume":"36","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108396_bib0004","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.vaccine.2017.08.024","article-title":"Diphtheria vaccine: WHO position paper, August 2017 \u2013 recommendations","volume":"36","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108396_bib0006","series-title":"WHO vaccine-preventable diseases: monitoring system. 2020 global summary","year":"2020"},{"key":"10.1016\/j.ijid.2026.108396_bib0007","unstructured":"Gavi. Kenya. Gavi: the Vaccine Alliance, 2025."},{"key":"10.1016\/j.ijid.2026.108396_bib0009","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.46.20313-en","article-title":"Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009","volume":"17","author":"Ladhani","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2026.108396_bib0010","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/tmi.12737","article-title":"Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries","volume":"21","author":"Cutts","year":"2016","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijid.2026.108396_bib0011","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/315535","article-title":"Diphtheria in the Russian Federation in the 1990s","volume":"181","author":"Markina","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108396_bib0012","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2471\/BLT.07.041129","article-title":"Towards elimination: measles susceptibility in Australia and 17 European countries","volume":"86","author":"Andrews","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2026.108396_bib0013","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.1.20998","article-title":"Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013","volume":"20","author":"Hens","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2026.108396_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127425","article-title":"Seroprevalence of immunoglobulin G against measles and rubella over a 12-year period (2009\u20132021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016","volume":"61","author":"Mburu","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108396_bib0015","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ije\/dys062","article-title":"Profile: the Kilifi health and demographic surveillance system (KHDSS)","volume":"41","author":"Scott","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ijid.2026.108396_bib0016","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1086\/430006","article-title":"Case definitions of clinical malaria under different transmission conditions in Kilifi District","volume":"191","author":"Mwangi","year":"2005","journal-title":"Kenya. J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108396_bib0017","unstructured":"PCVIS|Kemri. Wellcome Trust, https:\/\/kemri-wellcome.org\/programme\/pcvis-2\/; n.d. [accessed 23 August 2023]."},{"key":"10.1016\/j.ijid.2026.108396_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000883","article-title":"SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020\u2013May 2021","volume":"2","author":"Etyang","year":"2022","journal-title":"PLoS Glob Public Health"},{"key":"10.1016\/j.ijid.2026.108396_bib0019","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2214-109X(15)00316-2","article-title":"Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study","volume":"4","author":"Hammitt","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2026.108396_bib0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","article-title":"Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus","volume":"335","author":"van Gageldonk","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ijid.2026.108396_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103247","article-title":"Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: a collaborative study in Finland, the Netherlands, and the United Kingdom","volume":"65","author":"Versteegen","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijid.2026.108396_bib0022","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.47.17-00011","article-title":"Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection","volume":"22","author":"van der Lee","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2026.108396_bib0023","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4049\/jimmunol.54.4.325","article-title":"Circulating antitoxin at the onset of diphtheria in 425 patients","volume":"54","author":"Ipsen","year":"1946","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2026.108396_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014183","article-title":"Seroprevalence of pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis","volume":"5","author":"De Greeff","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2026.108396_bib0026","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/JCM.38.2.800-806.2000","article-title":"Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis","volume":"38","author":"De Melker","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2026.108396_bib0027","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/INF.0000000000000576","article-title":"Seroprevalence of pertussis in the Gambia: evidence for continued circulation of Bordetella pertussis despite high vaccination rates","volume":"34","author":"Scott","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijid.2026.108396_bib0028","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.abe1916","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors","volume":"371","author":"Uyoga","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ijid.2026.108396_bib0029","series-title":"R: A language and environment for statistical computing","author":"Team","year":"2016"},{"key":"10.1016\/j.ijid.2026.108396_bib0030","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1086\/315557","article-title":"Immunogenicity of tetanus-diphtheria toxoids (Td) among Ukrainian adults: implications for diphtheria control in the Newly Independent States of the Former Soviet Union","volume":"181","author":"Sutter","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108396_bib0031","first-page":"325","article-title":"Infection, immunity and disease in the epidemiology of diphtheria, with special reference to some studies in Baltimore","volume":"2","author":"Frost","year":"1928","journal-title":"J Prev Med"},{"key":"10.1016\/j.ijid.2026.108396_bib0032","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.1016\/j.vaccine.2018.11.005","article-title":"Coverage and timeliness of vaccination and the validity of routine estimates: insights from a vaccine registry in Kenya","volume":"36","author":"Adetifa","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108396_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001404","article-title":"Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys","volume":"10","author":"Cutts","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2026.108396_bib0034","first-page":"433","article-title":"Pertussis vaccines: WHO position paper\u2014August 2015","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ijid.2026.108396_bib0035","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/21645515.2016.1259780","article-title":"Immune persistence after pertussis vaccination","volume":"13","author":"Chen","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ijid.2026.108396_bib0036","unstructured":"World Health Organization. WHO Immunization Data portal - Detail Page. Immunization Data, https:\/\/immunizationdata.who.int\/global\/wiise-detail-page; [accessed 10 September 2025]."},{"key":"10.1016\/j.ijid.2026.108396_bib0038","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s13104-024-06930-5","article-title":"A recent history of disease outbreaks in Kenya, 2007\u20132022: findings from routine surveillance data","volume":"17","author":"Geteri","year":"2024","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ijid.2026.108396_bib0039","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1016\/j.vaccine.2013.07.015","article-title":"Seroepidemiology of diphtheria and tetanus among children and young adults in Tajikistan: nationwide population-based survey, 2010","volume":"31","author":"Khetsuriani","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108396_bib0040","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-136-9-200205070-00008","article-title":"Serologic immunity to diphtheria and tetanus in the United States","volume":"136","author":"McQuillan","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2026.108396_bib0041","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1001\/jama.1979.03300210024015","article-title":"Tetanus and diphtheria immunity in urban Minnesota adults","volume":"242","author":"Crossley","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2026.108396_bib0042","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/archpedi.1991.02160070030017","article-title":"A comparative trial of the reactogenicity and immunogenicity of Takeda acellular pertussis vaccine combined with tetanus and diphtheria toxoids. Outcome in 3- to 8-month-old infants, 9- to 23-month-old infants and children, and 24- to 30-month-old children","volume":"145","author":"Kimura","year":"1991","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.ijid.2026.108396_bib0043","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/cid\/ciw066","article-title":"Durability of vaccine-induced immunity against tetanus and diphtheria toxins: a cross-sectional analysis","volume":"62","author":"Hammarlund","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108396_bib0044","series-title":"Immunological basis for immunization: Molule 3 : Tetanus (update 2006)","author":"Borrow","year":"2007"},{"key":"10.1016\/j.ijid.2026.108396_bib0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4269\/ajtmh.16-0452","article-title":"Tetanus immunity gaps in children 5\u201314 years and men \u2265 15 years of age revealed by integrated disease serosurveillance in Kenya, Tanzania, and Mozambique","volume":"96","author":"Scobie","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2026.108396_bib0046","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1086\/315533","article-title":"The changing epidemiology of diphtheria in the vaccine era","volume":"181","author":"Galazka","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108396_bib0047","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S0950268899004161","article-title":"The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network","volume":"125","author":"Edmunds","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijid.2026.108396_bib0048","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF01719955","article-title":"Diphtheria: changing patterns in the developing world and the industrialized world","volume":"11","author":"Galazka","year":"1995","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ijid.2026.108396_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048684","article-title":"Seroprevalence of pertussis in Senegal: a prospective study","volume":"7","author":"Gaayeb","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2026.108396_bib0050","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.ijid.2026.108396_bib0051","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","article-title":"Duration of immunity against pertussis after natural infection or vaccination","volume":"24","author":"Wendelboe","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijid.2026.108396_bib0052","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1618883","article-title":"Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies","volume":"16","author":"Sheng","year":"2025","journal-title":"Front Immunol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226000317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226000317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:54:59Z","timestamp":1784548499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226000317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":48,"alternative-id":["S1201971226000317"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108396","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of antibodies against diphtheria, tetanus, and pertussis over a 12-year period in children in Kilifi, Kenya (2009-2021)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108396"}}